Company profile

Quantum Profit Growth

Bio: Geoff Cooper has over 30 years’ experience in senior management, business development, and sales and marketing roles with both large and small companies. From Information Technology technical systems engineering, through senior-level regional appointments, to CEO of an Australian software company, he has a broad range of experience and expertise to draw upon.

As CEO of Mastersoft Systems, Geoff engineered a successful business restructure, resurrecting company results and shareholder gains.

Previously, during his 20 years at Amdahl Corporation a multinational Information Technology manufacturer providing mission critical solutions to blue chip companies, he managed operations in Australia, Thailand and South East Asia.

Through his own consulting business (Quantum) Geoff assists clients to leverage sales and marketing activities through digital marketing.  Specialising in data analytics, Geoff helps build real value of client websites and internet marketing strategies through facts-based decision-making.
[Total: 1    Average: 5/5]

News & Trends - Medical Technology

MedTech News - Technology levels up support for healthcare employees - Matt Moran, MD, Philips

Technology levels up support for healthcare employees – Matt Moran, MD, Philips

Health Industry Hub | January 22, 2021 |

MedTech News: Matt Moran, Managing Director of Philips Australia & New Zealad, reflects on the impact of the COVID-19 pandemic […]

More


Medical

Aussie researchers receive $2.9m funding boost for multiple sclerosis

Health Industry Hub | January 22, 2021 |

Medical News: Twenty multiple sclerosis (MS) scientific research teams across the country will receive an important New Year funding injection […]

More


News & Trends - Biotechnology

Biotech News - AusBiotech renews agreements with international stakeholders

AusBiotech renews agreements with international stakeholders

Health Industry Hub | January 22, 2021 |

Biotech News: AusBiotech’s international partnerships have been extended, with new Memorandums of Understanding (MoU) signed with major international industry associations […]

More


News & Trends - Pharmaceuticals

Pharma News - AbbVie's phase 3 wins for Humira successor Skyrizi

AbbVie’s phase 3 wins for Humira successor Skyrizi

Health Industry Hub | January 22, 2021 |

Pharma News: AbbVie is in a race against time as patent expiry of its Humira inflammatory diseases blockbuster draws near […]

More